(NYSE: ATR) Aptargroup's forecast annual revenue growth rate of 3.11% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.82%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.37%.
Aptargroup's revenue in 2026 is $3,991,231,000.On average, 12 Wall Street analysts forecast ATR's revenue for 2026 to be $256,852,146,960, with the lowest ATR revenue forecast at $247,660,744,860, and the highest ATR revenue forecast at $268,515,719,280. On average, 12 Wall Street analysts forecast ATR's revenue for 2027 to be $265,726,604,160, with the lowest ATR revenue forecast at $251,210,527,740, and the highest ATR revenue forecast at $281,573,849,160.
In 2028, ATR is forecast to generate $278,150,844,240 in revenue, with the lowest revenue forecast at $260,845,652,700 and the highest revenue forecast at $294,061,478,220.